Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.20.2
Balance Sheet Components
9 Months Ended
Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

Property and Equipment, Net

Property and equipment consisted of the following (in thousands):

 

 

 

September 30,

2020

 

 

December 31,

2019

 

Leasehold improvements

 

$

3,268

 

 

$

3,268

 

Furniture, laboratory and office equipment

 

 

2,750

 

 

 

2,578

 

Computer equipment

 

 

159

 

 

 

253

 

Total property and equipment

 

 

6,177

 

 

 

6,099

 

Less accumulated depreciation and amortization

 

 

(2,508

)

 

 

(1,817

)

Property and equipment, net

 

$

3,669

 

 

$

4,282

 

 

Depreciation expense was $0.2 million and $0.7 million for the three and nine months ended September 30, 2020, respectively, compared to $0.2 million and $0.6 million for the three and nine months ended September 30, 2019, respectively.

 

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

 

 

 

September 30,

2020

 

 

December 31,

2019

 

Accrued preclinical and research costs

 

$

685

 

 

$

1,687

 

Accrued clinical costs

 

 

1,594

 

 

 

1,027

 

Accrued employee-related costs

 

 

1,198

 

 

 

1,293

 

Accrued professional services

 

 

227

 

 

 

53

 

Other

 

 

168

 

 

 

158

 

Total accrued liabilities

 

$

3,872

 

 

$

4,218